Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities

CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pharmacology & Therapeutics Unpaywall

CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities

Pharmacology & TherapeuticsNov 1, 2018
Loading next page...
 
/lp/unpaywall/cdk4-6-inhibitors-in-breast-cancer-therapy-current-practice-and-future-YPKE0ChqKc

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0163-7258
DOI
10.1016/j.pharmthera.2018.06.008
Publisher site
See Article on Publisher Site

Abstract

Journal

Pharmacology & TherapeuticsUnpaywall

Published: Nov 1, 2018

There are no references for this article.